Clear Street’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Clear Street’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.44K	Sell	218,765 -200	-0.1%	-$6	﹤0.01%	1010
2025 Q4	$5.69K	Sell	218,965 -600	-0.3%	-$21	﹤0.01%	819
2025 Q3	$7.73K	Sell	219,565 -200	-0.1%	-$7	﹤0.01%	700
2025 Q2	$8.99K	Buy	219,765 +74,600	+51%	+$3.95K	﹤0.01%	520
2025 Q1	$11.1K	Sell	145,165 -276	-0.2%	-$17	﹤0.01%	361
2024 Q4	$4.93K	Buy	145,441 +8,404	+6%	+$338	﹤0.01%	410
2024 Q3	$4.34K	Buy	+137,037	New	+$7.93K	﹤0.01%	477

Other funds holding SLXNW

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Clear Street's SLXNW Position: Q1 2026 in Review

Clear Street reduced its Silexion Therapeutics Warrant (SLXNW) stake by 0.09% in Q1 2026, selling an estimated $6 and leaving 218,765 shares worth $4.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Clear Street first reported a position in SLXNW in Q3 2024 and has held it in 7 quarters since. The position peaked at $11.1K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

Clear Street held 218,765 shares of Silexion Therapeutics Warrant worth $4.44K as of Q1 2026.
Clear Street sold 200 Silexion Therapeutics Warrant shares in Q1 2026, an estimated $6.
Silexion Therapeutics Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1010 holding.
Clear Street first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 7 quarters since.
Clear Street's Silexion Therapeutics Warrant position peaked at $11.1K in Q1 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.